WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or ...

(Reuters) - U.S. health regulators on Friday allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial ...

Pfizer Inc.’s stop-smoking pill Chantix has been linked to more than 3,000 reports in America of serious side effects, including suicides, heart trouble, and aggression, a study said. American ...

The Food and Drug Administration has been investigating reports of mood disorders and erratic behavior among Chantix patients since 2007. The agency said in a statement that two federally-funded ...

Kicking the habit can be hard enough, but smokers with depression face a steeper challenge. Now there’s evidence that the drug varenincline (Chantix) can help. About half of smokers who try to quit ...

On Thursday, Pfizer announced the results of a study of the safety and effectiveness of its Chantix smoking-cessation drug on relapsed smokers. The prognosis was good. Over the course of 12 weeks of ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. WASHINGTON • Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter ...

Numerous plain white pill bottles on a factory production line. When asking does Medicare cover Chantix, this could be where the bottle are filled. People 65 years old and older and those under 65 ...